Leading a diverse group of scientists encompassing all aspects of cell culture and bioreactor process development, characterization, and validation as well as technology transfer to cGMP manufacturing for perfusion and intensified fed-batch processes.

Collaborating across the organization to accelerate clinical development timelines, reduce development costs, and optimize strategies for process development and characterization for upstream bioreactor processes.

Defining and driving the technology development strategy for process intensification and continuous manufacturing to reduce manufacturing costs and footprint through improvements in culture productivity, control of product quality, and data management while working with...